According to ChemAnalyst, The Metoclopramide HCL Prices witnessed a notable upward trajectory during the first quarter of 2026, supported by increasing raw material costs, strong pharmaceutical manufacturing activity, and persistent supply chain disruptions across major producing regions. Rising petrochemical feedstock values, inflationary pressures, and elevated transportation expenses contributed significantly to the overall pricing environment. Despite moderate fluctuation
